|
| Lesinurad Impurity J Basic information |
Product Name: | Lesinurad Impurity J | Synonyms: | 2-((5-bromo-4-(naphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetic acid;Lesinurad Impurity 9 (Lesinurad Impurity E);Lesinurad Impurity J;Lesinurad Impurity 1/2-[[5-Bromo-4-(naphthalen-1-yl)-4H-1,2,4-triazol-3-yl]thio]-acetic Acid;Resinad Impurity I: Decyclocycloresinad;Acetic acid, 2-[[5-bromo-4-(1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]- | CAS: | 1210330-64-5 | MF: | C14H10BrN3O2S | MW: | 364.22 | EINECS: | | Product Categories: | | Mol File: | 1210330-64-5.mol | |
| Lesinurad Impurity J Chemical Properties |
Boiling point | 617.6±57.0 °C(Predicted) | density | 1.69±0.1 g/cm3(Predicted) | pka | 2.91±0.10(Predicted) |
| Lesinurad Impurity J Usage And Synthesis |
Uses | 2-[[5-Bromo-4-(naphthalen-1-yl)-4H-1,2,4-triazol-3-yl]thio]-acetic Acid is an impurity of drug Lesinurad (L329700), which is used to synthesize febuxostat which is a non-purine analog inhibitor of xanthine oxidase. Febuxostat is approved by the European Medicines Agency and the US Food and Drug Administration for treating gout. |
| Lesinurad Impurity J Preparation Products And Raw materials |
|